As patents expire on blockbuster biologic drugs, manufacturers are increasingly employing a controversial tactic known as “product hopping” to maintain […]
Source
Biologic Product Hopping: Innovation or Market Manipulation? Read Post »
Annual Drug Patent Expirations for WINLEVI Winlevi is a drug marketed by Sun Pharm and is included in one NDA. […]
Source
New patent expiration for Sun Pharm drug WINLEVI Read Post »
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Slovakia. SPCs are used in European […]
Source
Which pharmaceutical companies have the most SPCs in Slovakia? Read Post »
In the ever-evolving landscape of pharmaceutical development, excipient formulation strategies have become a critical focus for new developers. As the industry grapples with increasingly complex drug molecules and delivery challenges, innovative approa…
The biotech industry is known for its high-risk, high-reward nature, with early-stage companies facing significant challenges in securing funding to
Enantiomer Switching: A Pharmaceutical Strategy to Extend Drug Patents Enantiomer switching, also known as chiral switching, is a strategy employed […]
Source
The Chiral Switch: A Pharmaceutical Tactic to Prolong Exclusivity Read Post »
Annual Drug Patent Expirations for LUMAKRAS Lumakras is a drug marketed by Amgen Inc and is included in one NDA. […]
Source
Annual Drug Patent Expirations for ARIKAYCE+KIT Arikayce Kit is a drug marketed by Insmed Inc and is included in one […]
Source
Annual Drug Patent Expirations for RUBRACA Rubraca is a drug marketed by Zr Pharma and is included in one NDA. […]
Source
New patent expiration for Zr Pharma drug RUBRACA Read Post »
Get new actionable insights and updates from BiotechBlog
